Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 1;327(6):L917-L929.
doi: 10.1152/ajplung.00280.2023. Epub 2024 Oct 22.

Longitudinal microcomputed tomography detects onset and progression of pulmonary fibrosis in conditional Nedd4-2 deficient mice

Affiliations

Longitudinal microcomputed tomography detects onset and progression of pulmonary fibrosis in conditional Nedd4-2 deficient mice

Dominik H W Leitz et al. Am J Physiol Lung Cell Mol Physiol. .

Abstract

Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease, which is usually diagnosed late in advanced stages. Little is known about the subclinical development of IPF. We previously generated a mouse model with conditional Nedd4-2 deficiency (Nedd4-2-/-) that develops IPF-like lung disease. The aim of this study was to characterize the onset and progression of IPF-like lung disease in conditional Nedd4-2-/- mice by longitudinal micro-computed tomography (CT). In vivo micro-CT was performed longitudinally in control and conditional Nedd4-2-/- mice at 1, 2, 3, 4, and 5 mo after doxycycline induction. Furthermore, terminal in vivo micro-CT followed by pulmonary function testing and post mortem micro-CT was performed in age-matched mice. Micro-CT images were evaluated for pulmonary fibrosis using an adapted fibrosis scoring system. Histological assessment of lung collagen content was conducted as well. Micro-CT is sensitive to detect the onset and progression of pulmonary fibrosis in vivo and to quantify distinct radiological IPF-like features along disease development in conditional Nedd4-2-/- mice. Nonspecific interstitial alterations were detected from 3 mo, whereas key features such as honeycombing-like lesions were detected from 4 mo onward. Pulmonary function correlated well with in vivo (r = -0.738) and post mortem (r = -0.633) micro-CT fibrosis scores and collagen content. Longitudinal micro-CT enables in vivo monitoring of the onset and progression and detects radiological key features of IPF-like lung disease in conditional Nedd4-2-/- mice. Our data support micro-CT as a sensitive quantitative endpoint for the preclinical evaluation of novel antifibrotic strategies.NEW & NOTEWORTHY IPF diagnosis, particularly in early stages, remains challenging. In this study, micro-CT is used in conditional Nedd4-2-/- mice to closely monitor the onset and progression of progressive pulmonary fibrosis in vivo. Together with high-resolution post mortem micro-CT, this allowed us to track how nonspecific lung lesions develop into key IPF-like features. This approach offers a noninvasive method to monitor pulmonary fibrosis, providing a quantitative endpoint for the preclinical evaluation of novel antifibrotic strategies.

Keywords: IPF; Nedd4-2; animal model; idiopathic pulmonary fibrosis; micro-CT.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest, financial or otherwise, are declared by the authors.

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Longitudinal in vivo micro-CT detects onset and progression of pulmonary fibrosis in conditional Nedd4-2−/− mice. A: schematic illustration of the longitudinal study design with serial in vivo micro-CT 1, 2, 3, 4, and 5 mo after doxycycline induction of conditional Nedd4-2−/− mice and controls. B: summary of in vivo micro-CT fibrosis scores assessed by longitudinal micro-CT. C: representative longitudinal in vivo micro-CT image of a spontaneously breathing conditional Nedd4-2−/− mouse scanned at the indicated time points after doxycycline induction. Fibrotic areas are indicated in blue. D: 3-D reconstructions of fibrotic lesions (blue) in the lung of the same mouse as shown in C after 2, 3, 4, and 5 mo of doxycycline induction. n = 5–15 mice/group. *P < 0.05, ***P < 0.001. 3-D, three-dimensional; micro-CT, micro-computed tomography.
Figure 2.
Figure 2.
Comparison of radiological features determined by in vivo and post mortem micro-CT during the development of IPF-like lung disease in conditional Nedd4-2−/− mice. A: study design of cross-sectional micro-CT imaging during the development of IPF-like lung disease in conditional Nedd4-2−/− mice using in vivo micro-CT imaging followed by pulmonary function testing (PFT) and a post mortem micro-CT scan after 1, 2, 3, 4, and 5 mo of doxycycline induction. B and C: representative in vivo micro-CT images in spontaneously breathing conditional Nedd4-2−/− mice (B) and post mortem micro-CT (C) at indicated time points. D: Comparison of consolidations (red asterisks), honeycombing-like lesions (black arrowheads), peripheral bronchiectasis (white arrows), parenchymal lines (black arrows), and reticulations (white arrowheads) in in vivo and post mortem micro-CT 4 mo after conditional Nedd4-2 deletion. IPF, idiopathic pulmonary fibrosis; micro-CT, micro-computed tomography.
Figure 3.
Figure 3.
Development of radiological features of IPF-like lung disease in conditional Nedd4-2−/− mice. A: in vivo micro-CT fibrosis score along disease development after 1, 2, 3, 4, and 5 mo of doxycycline induction in conditional Nedd4-2−/− mice and controls. Post mortem micro-CT fibrosis score (B), consolidations (C), honeycombing-like lesions (D), fissural thickening (E), peripheral bronchiectasis (F), parenchymal lines (G), and reticulations (H) detected by high-resolution micro-CT in conditional Nedd4-2−/− mice and controls. Females are indicated as filled circles, males are indicated as open circles. n = 5–12 mice/group. FDR-adjusted P values are indicated as *P < 0.05, **P < 0.01, ***P < 0.001. IPF, idiopathic pulmonary fibrosis; micro-CT, microcomputed tomography.
Figure 4.
Figure 4.
Micro-CT fibrosis score negatively correlates with impairment in pulmonary function in conditional Nedd4-2−/− mice. A: correlation between fibrosis scores determined by in vivo micro-CT and post mortem micro-CT. n = 31 mice. B: representative micrographs of H&E-stained lung sections of 4-mo-induced conditional Nedd4-2−/− and control mice. Low magnification (left, scale bar 2.5 mm). Consolidations (red asterisks), honeycombing-like lesions (black arrowheads), and peripheral bronchiectasis (white arrows). Higher magnification of cystic structural lung damages in the periphery of the lung (bottom right image, scale bar 100 µm). C: representative micrographs of histological sections stained for picrosirius red from 4-mo-induced conditional Nedd4-2−/− and control mice at low (left, scale bar 2.5 mm) and high magnifications (right, scale bar 100 µm). D: quantification of collagen in picrosirius red-stained lung sections showing the collagen area fraction in controls and conditional Nedd4-2−/− mice after the indicated periods of induction. n = 3–6 mice/group. Correlation between collagen area fraction and in vivo micro-CT fibrosis score (E) or post mortem micro-CT fibrosis score (F). n = 22 mice. G: summary of lung compliance at different time points in conditional Nedd4-2−/− mice compared with controls. n = 3–7 mice/group. Correlation between lung compliance determined by pulmonary function testing and in vivo micro-CT fibrosis score (H) (n = 35 mice) and post mortem micro-CT fibrosis score (I) (n = 37 mice) in conditional Nedd4-2−/− mice. Females are indicated as filled circles, males are indicated as open circles. *P < 0.05, **P < 0.01. Spearman rank order correlation coefficient (r), and P values are provided. H&E, hematoxylin and eosin; micro-CT, microcomputed tomography.
Figure 5.
Figure 5.
Micro-CT of end-stage IPF-like lung disease in moribund conditional Nedd4-2−/− mice. A: development of fibrosis scores in longitudinal micro-CT imaging studies of moribund conditional Nedd4-2−/− mice that had to be euthanized vs. conditional Nedd4-2−/− mice from the longitudinal study group that survived 5 mo of doxycycline induction. B: representative post mortem micro-CT images of a surviving conditional Nedd4-2−/− mouse and a moribund mouse that had to be euthanized after 4.5 mo. Summary of the post mortem micro-CT fibrosis scores (C), and the subscores for quantification of consolidation (D), honeycombing-like lesions (E), fissural thickening (F), peripheral bronchiectasis (G), parenchymal lines (H) and reticulations (I). n = 4–11 mice/group. *P < 0.05, **P < 0.01. IPF, idiopathic pulmonary fibrosis. micro-CT, microcomputed tomography.

References

    1. Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, , et al. . Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 205: e18–e47, 2022. doi:10.1164/rccm.202202-0399ST. - DOI - PMC - PubMed
    1. King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet (Lancet 378: 1949–1961, 2011. doi:10.1016/S0140-6736(11)60052-4. - DOI - PubMed
    1. Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, Swigris JJ, Taniguchi H, Wells AU. Idiopathic pulmonary fibrosis. Nat Rev Dis Primers 3: 17074, 2017. doi:10.1038/nrdp.2017.74. - DOI - PubMed
    1. Wolters PJ, Collard HR, Jones KD. Pathogenesis of Idiopathic Pulmonary Fibrosis. Annu Rev Pathol 9: 157–179, 2014. doi:10.1146/annurev-pathol-012513-104706. - DOI - PMC - PubMed
    1. Fernandez IE, Eickelberg O. New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis. Lancet 380: 680–688, 2012. doi:10.1016/S0140-6736(12)61144-1. - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources